CRYSTAL_EQUITY

Caplin point may test 1600+

Long
NSE:CAPLIPOINT   CAPLIN POINT LABOR
Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations.
Pharma sector in bull mode
Cmp 1488
stop 1450
target 1600
risk reward 1:2
Holding period 15days
after a good breakout retested 10Ema
bouncing up
volume also picks up
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.